| 1 | covariates | 2,553 |
| 2 | demographics | 2,089 |
| 3 | confounders | 1,578 |
| 4 | vanilloid | 138 |
| 5 | sociodemographics | 95 |
| 6 | demography | 77 |
| 7 | aneuploidies | 71 |
| 8 | covariables | 68 |
| 9 | confounds | 61 |
| 10 | socio-demographics | 45 |
| 11 | melastatin | 30 |
| 12 | co-factors | 25 |
| 13 | co-variates | 20 |
| 14 | co-variables | 18 |
| 15 | signalment | 18 |
| 16 | precipitants | 15 |
| 17 | lipin-1 | 13 |
| 18 | re-experiencing | 13 |
| 19 | borderlines | 11 |
| 20 | catharsis | 11 |
| 21 | misclassifications | 10 |
| 22 | awes | 9 |
| 23 | qlfts | 9 |
| 24 | 8mg/d | 8 |
| 25 | acutum | 8 |
| 26 | donuts | 8 |
| 27 | maskers | 8 |
| 28 | non-randomisation | 8 |
| 29 | vanilloid-1 | 8 |
| 30 | i-sfn | 7 |
| 31 | auc0-36 | 6 |
| 32 | micro-nutrients | 6 |
| 33 | non-randomization | 6 |
| 34 | phhs | 6 |
| 35 | tac-b.i.d | 6 |
| 36 | tac-q.d | 6 |
| 37 | 80-120mg/d | 5 |
| 38 | astrology | 5 |
| 39 | beta-subunits | 5 |
| 40 | cohabitants | 5 |
| 41 | descriptives | 5 |
| 42 | hivdd | 5 |
| 43 | nct00801502 | 5 |
| 44 | neonicotinoids | 5 |
| 45 | plasticisers | 5 |
| 46 | pufa- | 5 |
| 47 | snappi | 5 |
| 48 | superioris | 5 |
| 49 | wholeness | 5 |
| 50 | β-1,3-galactan | 5 |
| 51 | alpha-lf | 4 |
| 52 | ambidexterity | 4 |
| 53 | anti-chitobioside | 4 |
| 54 | bridgers | 4 |
| 55 | caricatures | 4 |
| 56 | cellulitis/erysipelas | 4 |
| 57 | cofounders | 4 |
| 58 | dwi-spair | 4 |
| 59 | e180g | 4 |
| 60 | genotoxicants | 4 |
| 61 | hypoliths | 4 |
| 62 | immunoreactants | 4 |
| 63 | interferents | 4 |
| 64 | kinesins | 4 |
| 65 | kitakomachi | 4 |
| 66 | laryngopharyngitis | 4 |
| 67 | natriuresis/diuresis | 4 |
| 68 | nonasthmatics | 4 |
| 69 | phosphanes | 4 |
| 70 | pq1 | 4 |
| 71 | pyri | 4 |
| 72 | radiopeptides | 4 |
| 73 | turbinata | 4 |
| 74 | t→∞ | 4 |
| 75 | acei+g | 3 |
| 76 | adcmin | 3 |
| 77 | alachlor | 3 |
| 78 | angioprevention | 3 |
| 79 | atfs | 3 |
| 80 | azodicarbonamide | 3 |
| 81 | b-nhls | 3 |
| 82 | biomechanisms | 3 |
| 83 | ceo/ml | 3 |
| 84 | cholecystocholedocholithiasis | 3 |
| 85 | cilobradine | 3 |
| 86 | co-pays | 3 |
| 87 | coulometry | 3 |
| 88 | d12sac010202 | 3 |
| 89 | d175n | 3 |
| 90 | distant-ffr | 3 |
| 91 | ferd | 3 |
| 92 | gliz | 3 |
| 93 | hemidystonia | 3 |
| 94 | il1beta-511 | 3 |
| 95 | incentive* | 3 |
| 96 | invasives | 3 |
| 97 | mechanotransducers | 3 |
| 98 | non-enrolment | 3 |
| 99 | obscurus | 3 |
| 100 | oral-antidiabetics | 3 |
| 101 | outcomes.overall | 3 |
| 102 | p.a150p | 3 |
| 103 | pfhrp2-detection | 3 |
| 104 | ppd/ppp | 3 |
| 105 | r-fluoxetine | 3 |
| 106 | rebound/relapse | 3 |
| 107 | romosinuano-brahman | 3 |
| 108 | rosuvastatine | 3 |
| 109 | rs3744028 | 3 |
| 110 | self-battery | 3 |
| 111 | sum-149 | 3 |
| 112 | trichoscan® | 3 |
| 113 | wadal | 3 |
| 114 | μg.min/ml | 3 |
| 115 | 11q22.3-q23.3 | 2 |
| 116 | 12-24weeks | 2 |
| 117 | 19-norprogesterones | 2 |
| 118 | 1980-1987 | 2 |
| 119 | 1994/95 | 2 |
| 120 | 1h-1,2,3-triazolylbenzohydrazides | 2 |
| 121 | 2-chloro-des | 2 |
| 122 | 2-methyl-1,3-dioxolane | 2 |
| 123 | 7,7'-biphenyl-2,2'-bitropone | 2 |
| 124 | ag85c | 2 |
| 125 | algimycin-pwf | 2 |
| 126 | allergologists | 2 |
| 127 | antihypercholesterolaemic | 2 |
| 128 | astronomers | 2 |
| 129 | atheroprevention | 2 |
| 130 | auc0-7days | 2 |
| 131 | b-pa-z | 2 |
| 132 | bedding-in | 2 |
| 133 | bi-pap | 2 |
| 134 | bio-applications | 2 |
| 135 | bip-135 | 2 |
| 136 | boulevards | 2 |
| 137 | cam5.2 | 2 |
| 138 | children-iv | 2 |
| 139 | chx+xpb | 2 |
| 140 | clic1 | 2 |
| 141 | cnbss-1 | 2 |
| 142 | cnbss-2 | 2 |
| 143 | colipase | 2 |
| 144 | contactability | 2 |
| 145 | cross-tables | 2 |
| 146 | ctg-monitoring | 2 |
| 147 | deltal | 2 |
| 148 | dha-status | 2 |
| 149 | disbenefits | 2 |
| 150 | eeg-regulators | 2 |
| 151 | fbdc | 2 |
| 152 | fcv-9 | 2 |
| 153 | ffff | 2 |
| 154 | fimtm | 2 |
| 155 | fiproles | 2 |
| 156 | firestem2d | 2 |
| 157 | gd-do3a-butrol | 2 |
| 158 | gd-dtpa-bmea | 2 |
| 159 | ghs/qol | 2 |
| 160 | ha-utis | 2 |
| 161 | handpicking | 2 |
| 162 | hast-aqp4 | 2 |
| 163 | him- | 2 |
| 164 | his200 | 2 |
| 165 | hpv59 | 2 |
| 166 | hydrozincite | 2 |
| 167 | inclusion.we | 2 |
| 168 | iso-lines | 2 |
| 169 | isrctn02309506 | 2 |
| 170 | isrctn06477126 | 2 |
| 171 | isrctn43453770 | 2 |
| 172 | kidney-essence | 2 |
| 173 | kids™ | 2 |
| 174 | lev/cbz-cr | 2 |
| 175 | luteolin-7-o-gentiobioside | 2 |
| 176 | lvdys-6 | 2 |
| 177 | m-iv | 2 |
| 178 | mcpr3-7 | 2 |
| 179 | microcomputers | 2 |
| 180 | mlh-1 | 2 |
| 181 | mmf/pred | 2 |
| 182 | mucolipin | 2 |
| 183 | multiplus | 2 |
| 184 | nct00000608 | 2 |
| 185 | nct00183001 | 2 |
| 186 | nct00197730 | 2 |
| 187 | necaxantle | 2 |
| 188 | non-recruitment | 2 |
| 189 | nonapproach | 2 |
| 190 | osteoinductivity | 2 |
| 191 | over-50s | 2 |
| 192 | p-gc | 2 |
| 193 | paromomycin-gentamicin | 2 |
| 194 | physiologic/structural | 2 |
| 195 | phytotoxins | 2 |
| 196 | pore-filling | 2 |
| 197 | pre-exercise/rest | 2 |
| 198 | pregnancy/family | 2 |
| 199 | risk-cost | 2 |
| 200 | roughing | 2 |
| 201 | rs4245791 | 2 |
| 202 | rs5277 | 2 |
| 203 | selection- | 2 |
| 204 | self-centering | 2 |
| 205 | sensitinogen | 2 |
| 206 | sharklet™ | 2 |
| 207 | spirolides | 2 |
| 208 | tavorite-mg0.5feso4f | 2 |
| 209 | tcse2 | 2 |
| 210 | tenatoprazole | 2 |
| 211 | teratogenity | 2 |
| 212 | terre-de-bas | 2 |
| 213 | thermopriming | 2 |
| 214 | umin000001841 | 2 |
| 215 | ureum | 2 |
| 216 | vannilloid | 2 |
| 217 | vulva/vagina | 2 |
| 218 | web-sites | 2 |
| 219 | wirths | 2 |
| 220 | xyl1 | 2 |
| 221 | zmat3 | 2 |
| 222 | α-adrenoceptors | 2 |
| 223 | αba | 2 |
| 224 | 'adaptation-control | 1 |
| 225 | -nausea | 1 |
| 226 | 0.9≤abi≤1.3 | 1 |
| 227 | 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin | 1 |
| 228 | 1-oh-mc/hsult1b1 | 1 |
| 229 | 123-iodine | 1 |
| 230 | 12h/d | 1 |
| 231 | 13c6-d-glucose | 1 |
| 232 | 14,278 | 1 |
| 233 | 15-60min | 1 |
| 234 | 174d | 1 |
| 235 | 181c | 1 |
| 236 | 1973-2012 | 1 |
| 237 | 1h/day/21days | 1 |
| 238 | 2005-12 | 1 |
| 239 | 21/28days | 1 |
| 240 | 2decho | 1 |
| 241 | 3.2m | 1 |
| 242 | 3.5months | 1 |
| 243 | 31days | 1 |
| 244 | 365.3person-years | 1 |
| 245 | 43b | 1 |
| 246 | 48months | 1 |
| 247 | 5.3h | 1 |
| 248 | 75h | 1 |
| 249 | 79h | 1 |
| 250 | ablatives | 1 |
| 251 | acr20/70 | 1 |
| 252 | adresses | 1 |
| 253 | afasi | 1 |
| 254 | afg3l2 | 1 |
| 255 | al* | 1 |
| 256 | ald.3 | 1 |
| 257 | aldh9a1 | 1 |
| 258 | analgesie | 1 |
| 259 | androgen-boosting | 1 |
| 260 | anthicolinergics | 1 |
| 261 | anti-tuberculars | 1 |
| 262 | antitreatment | 1 |
| 263 | aphakics | 1 |
| 264 | appes | 1 |
| 265 | aspirin/pravastatin | 1 |
| 266 | asrgl1 | 1 |
| 267 | assistant-sitting | 1 |
| 268 | augment* | 1 |
| 269 | b3-b5 | 1 |
| 270 | balloon-oversizing | 1 |
| 271 | benzoylecgnonine | 1 |
| 272 | beta-2-receptors | 1 |
| 273 | biochars/hydrochars | 1 |
| 274 | bioinoculants | 1 |
| 275 | blactx-m14 | 1 |
| 276 | body-temperature-and-pressure-saturated | 1 |
| 277 | c1qb | 1 |
| 278 | calibration-curves | 1 |
| 279 | canonical-3 | 1 |
| 280 | carbapenem-colistin | 1 |
| 281 | causes.2 | 1 |
| 282 | cefotaxim/sulbactam | 1 |
| 283 | cell-cell-adhesion | 1 |
| 284 | ceni0.2pd0.8in | 1 |
| 285 | centromere- | 1 |
| 286 | chiropodists/podiatrists | 1 |
| 287 | chloroquine-artesunate | 1 |
| 288 | cholesterol-reducer | 1 |
| 289 | cis-prenyltransferases | 1 |
| 290 | cns-symptoms | 1 |
| 291 | colon-ovarian-tumor-antigen | 1 |
| 292 | confounders.thus | 1 |
| 293 | counterfeiters | 1 |
| 294 | crinanes | 1 |
| 295 | crls1 | 1 |
| 296 | cta-pe | 1 |
| 297 | cu2zn0.4fe0.6snse4 | 1 |
| 298 | cytokeratin-7 | 1 |
| 299 | d.farinae | 1 |
| 300 | data-triangulation | 1 |
| 301 | daytime-abpm | 1 |
| 302 | death.am | 1 |
| 303 | deconfounding | 1 |
| 304 | depression-anxiety-panic | 1 |
| 305 | dffb | 1 |
| 306 | diabetes/prediabetes | 1 |
| 307 | dic-syndrome | 1 |
| 308 | discontinuation/safety | 1 |
| 309 | disease-self-management | 1 |
| 310 | disease-subtypes | 1 |
| 311 | dispensarisation | 1 |
| 312 | doctor-patient-relationships | 1 |
| 313 | dyslipidemiae | 1 |
| 314 | east-asians | 1 |
| 315 | ecphr | 1 |
| 316 | egg-donors | 1 |
| 317 | electropolished-benchmark-samples | 1 |
| 318 | eons | 1 |
| 319 | ethylcellulose/soluplus® | 1 |
| 320 | examinion | 1 |
| 321 | f-18-fdg-pet/ct | 1 |
| 322 | fathers/children | 1 |
| 323 | fine-typing | 1 |
| 324 | flare/non-response | 1 |
| 325 | foetotoxic | 1 |
| 326 | fom-tromethamine | 1 |
| 327 | fritaa | 1 |
| 328 | galacturonamide | 1 |
| 329 | gamebirds | 1 |
| 330 | gamma-pyrone | 1 |
| 331 | genotoxicity/clastogenicity | 1 |
| 332 | glucostrophalloside | 1 |
| 333 | gvpi | 1 |
| 334 | ha-1/ha-3 | 1 |
| 335 | hexafunctionalized | 1 |
| 336 | hna-5b | 1 |
| 337 | hplc-uv-detection | 1 |
| 338 | hpv-6-11-18 | 1 |
| 339 | hpv-74 | 1 |
| 340 | hpv-typing | 1 |
| 341 | hsa-telmisartan | 1 |
| 342 | hsbf | 1 |
| 343 | hypermenorrhae | 1 |
| 344 | hypo-fertility | 1 |
| 345 | hypochodriasis | 1 |
| 346 | ibs-patients | 1 |
| 347 | ifn-action | 1 |
| 348 | iga-nephropathy | 1 |
| 349 | igf-1/il-6 | 1 |
| 350 | immunoquantitation | 1 |
| 351 | imp3/glut-1 | 1 |
| 352 | in-mates | 1 |
| 353 | indapamide-trials | 1 |
| 354 | infant/newborn | 1 |
| 355 | inflamtion | 1 |
| 356 | interva-3 | 1 |
| 357 | isorynchophylline | 1 |
| 358 | isovolumic-sr | 1 |
| 359 | jdentalcare | 1 |
| 360 | jo2-hepatitis | 1 |
| 361 | kind-relevant | 1 |
| 362 | l1-l4a | 1 |
| 363 | laryngectomess | 1 |
| 364 | laryngopathy | 1 |
| 365 | leguminosae-caesalpinoideae | 1 |
| 366 | leu213 | 1 |
| 367 | lnauc0-∞ | 1 |
| 368 | masking-or | 1 |
| 369 | mediators-self-efficacy | 1 |
| 370 | mednar | 1 |
| 371 | melanomagenesis | 1 |
| 372 | melastatin-3 | 1 |
| 373 | melastatin-like | 1 |
| 374 | mir-124-1 | 1 |
| 375 | miscibilities | 1 |
| 376 | mouthbreathing | 1 |
| 377 | mrtps | 1 |
| 378 | msm.2 | 1 |
| 379 | multifocality/recurrence | 1 |
| 380 | n.h.s | 1 |
| 381 | n=15-20 | 1 |
| 382 | nabhs | 1 |
| 383 | nagss | 1 |
| 384 | nano-dnt | 1 |
| 385 | nct00279682 | 1 |
| 386 | neoliberalization | 1 |
| 387 | nephropathogenicity | 1 |
| 388 | neuro-therapeutics | 1 |
| 389 | neuroprotectors | 1 |
| 390 | nf+fs | 1 |
| 391 | no-fill | 1 |
| 392 | non-abuse | 1 |
| 393 | non-attendence | 1 |
| 394 | non-dermatologist | 1 |
| 395 | non-high-velocity | 1 |
| 396 | non-ophthalmologists | 1 |
| 397 | non-stemis | 1 |
| 398 | nonepileptics | 1 |
| 399 | n≤4 | 1 |
| 400 | obesogen | 1 |
| 401 | odi/ahi | 1 |
| 402 | oftocotrienol | 1 |
| 403 | organization/analysis | 1 |
| 404 | over-reassurance | 1 |
| 405 | oxide-electronics | 1 |
| 406 | p.arg149cys | 1 |
| 407 | p24ag | 1 |
| 408 | pain/distress | 1 |
| 409 | palaeoflora | 1 |
| 410 | panicogen | 1 |
| 411 | parents/children | 1 |
| 412 | patients-without | 1 |
| 413 | pelotherapy | 1 |
| 414 | pentavalents | 1 |
| 415 | perception-altering | 1 |
| 416 | peroxins | 1 |
| 417 | pethidine/promethazine | 1 |
| 418 | photosensitivity/photorefractoriness | 1 |
| 419 | post-diesel | 1 |
| 420 | post-test-results | 1 |
| 421 | posterity | 1 |
| 422 | poststain | 1 |
| 423 | practice.2 | 1 |
| 424 | preschool-children | 1 |
| 425 | preswim | 1 |
| 426 | psychoses-montreal | 1 |
| 427 | psychosis/agitation | 1 |
| 428 | q24h/q12h | 1 |
| 429 | qd1-7 | 1 |
| 430 | r-population | 1 |
| 431 | rbt-gat | 1 |
| 432 | reciprocator | 1 |
| 433 | recorrenced | 1 |
| 434 | reencoding | 1 |
| 435 | rep+10'dex | 1 |
| 436 | responder-rates | 1 |
| 437 | ribosides | 1 |
| 438 | rmi1 | 1 |
| 439 | rp×rp | 1 |
| 440 | rs12379183 | 1 |
| 441 | rvr-achievers | 1 |
| 442 | saa/vsaa | 1 |
| 443 | scc150 | 1 |
| 444 | self-induction | 1 |
| 445 | sensitizers/irritants | 1 |
| 446 | sex-specificity | 1 |
| 447 | shanghai-china | 1 |
| 448 | shininess/oiliness | 1 |
| 449 | shortlisting | 1 |
| 450 | slc22a2/oct2 | 1 |
| 451 | snitrosohemoglobin | 1 |
| 452 | stomy | 1 |
| 453 | study.similarly | 1 |
| 454 | sulfapral | 1 |
| 455 | surface-hardening | 1 |
| 456 | thalamotomies | 1 |
| 457 | themotherapy | 1 |
| 458 | therapeuty | 1 |
| 459 | thermo-sensitizer | 1 |
| 460 | thiol-reactivity | 1 |
| 461 | thrombolysis-caused | 1 |
| 462 | tlhogwana | 1 |
| 463 | tooth-conserving | 1 |
| 464 | totpar-6 | 1 |
| 465 | toxiphores | 1 |
| 466 | trans-2,3-dideuterooxirane | 1 |
| 467 | transcystic-cholangiography | 1 |
| 468 | tvr-lead-in-nr | 1 |
| 469 | uchl-1 | 1 |
| 470 | um06 | 1 |
| 471 | under-preparation | 1 |
| 472 | underascertainment | 1 |
| 473 | unhsps | 1 |
| 474 | unicoronal | 1 |
| 475 | uro-oncologists | 1 |
| 476 | vallanoid | 1 |
| 477 | vanilloid1 | 1 |
| 478 | variables-expectation | 1 |
| 479 | video-tapes | 1 |
| 480 | vitligo | 1 |
| 481 | vsss | 1 |
| 482 | wcvs | 1 |
| 483 | wu-comparisons | 1 |
| 484 | y143r | 1 |
| 485 | β-cedrene- | 1 |
| 486 | β-fructofuranosidases | 1 |
| 487 | ψm | 1 |
| 488 | ∆mip | 1 |
| 1 | 'adaptation-control | 1 |
| 2 | -nausea | 1 |
| 3 | 0.9≤abi≤1.3 | 1 |
| 4 | 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin | 1 |
| 5 | 1-oh-mc/hsult1b1 | 1 |
| 6 | 11q22.3-q23.3 | 2 |
| 7 | 12-24weeks | 2 |
| 8 | 123-iodine | 1 |
| 9 | 12h/d | 1 |
| 10 | 13c6-d-glucose | 1 |
| 11 | 14,278 | 1 |
| 12 | 15-60min | 1 |
| 13 | 174d | 1 |
| 14 | 181c | 1 |
| 15 | 19-norprogesterones | 2 |
| 16 | 1973-2012 | 1 |
| 17 | 1980-1987 | 2 |
| 18 | 1994/95 | 2 |
| 19 | 1h-1,2,3-triazolylbenzohydrazides | 2 |
| 20 | 1h/day/21days | 1 |
| 21 | 2-chloro-des | 2 |
| 22 | 2-methyl-1,3-dioxolane | 2 |
| 23 | 2005-12 | 1 |
| 24 | 21/28days | 1 |
| 25 | 2decho | 1 |
| 26 | 3.2m | 1 |
| 27 | 3.5months | 1 |
| 28 | 31days | 1 |
| 29 | 365.3person-years | 1 |
| 30 | 43b | 1 |
| 31 | 48months | 1 |
| 32 | 5.3h | 1 |
| 33 | 7,7'-biphenyl-2,2'-bitropone | 2 |
| 34 | 75h | 1 |
| 35 | 79h | 1 |
| 36 | 80-120mg/d | 5 |
| 37 | 8mg/d | 8 |
| 38 | ablatives | 1 |
| 39 | acei+g | 3 |
| 40 | acr20/70 | 1 |
| 41 | acutum | 8 |
| 42 | adcmin | 3 |
| 43 | adresses | 1 |
| 44 | afasi | 1 |
| 45 | afg3l2 | 1 |
| 46 | ag85c | 2 |
| 47 | al* | 1 |
| 48 | alachlor | 3 |
| 49 | ald.3 | 1 |
| 50 | aldh9a1 | 1 |
| 51 | algimycin-pwf | 2 |
| 52 | allergologists | 2 |
| 53 | alpha-lf | 4 |
| 54 | ambidexterity | 4 |
| 55 | analgesie | 1 |
| 56 | androgen-boosting | 1 |
| 57 | aneuploidies | 71 |
| 58 | angioprevention | 3 |
| 59 | anthicolinergics | 1 |
| 60 | anti-chitobioside | 4 |
| 61 | anti-tuberculars | 1 |
| 62 | antihypercholesterolaemic | 2 |
| 63 | antitreatment | 1 |
| 64 | aphakics | 1 |
| 65 | appes | 1 |
| 66 | aspirin/pravastatin | 1 |
| 67 | asrgl1 | 1 |
| 68 | assistant-sitting | 1 |
| 69 | astrology | 5 |
| 70 | astronomers | 2 |
| 71 | atfs | 3 |
| 72 | atheroprevention | 2 |
| 73 | auc0-36 | 6 |
| 74 | auc0-7days | 2 |
| 75 | augment* | 1 |
| 76 | awes | 9 |
| 77 | azodicarbonamide | 3 |
| 78 | b-nhls | 3 |
| 79 | b-pa-z | 2 |
| 80 | b3-b5 | 1 |
| 81 | balloon-oversizing | 1 |
| 82 | bedding-in | 2 |
| 83 | benzoylecgnonine | 1 |
| 84 | beta-2-receptors | 1 |
| 85 | beta-subunits | 5 |
| 86 | bi-pap | 2 |
| 87 | bio-applications | 2 |
| 88 | biochars/hydrochars | 1 |
| 89 | bioinoculants | 1 |
| 90 | biomechanisms | 3 |
| 91 | bip-135 | 2 |
| 92 | blactx-m14 | 1 |
| 93 | body-temperature-and-pressure-saturated | 1 |
| 94 | borderlines | 11 |
| 95 | boulevards | 2 |
| 96 | bridgers | 4 |
| 97 | c1qb | 1 |
| 98 | calibration-curves | 1 |
| 99 | cam5.2 | 2 |
| 100 | canonical-3 | 1 |
| 101 | carbapenem-colistin | 1 |
| 102 | caricatures | 4 |
| 103 | catharsis | 11 |
| 104 | causes.2 | 1 |
| 105 | cefotaxim/sulbactam | 1 |
| 106 | cell-cell-adhesion | 1 |
| 107 | cellulitis/erysipelas | 4 |
| 108 | ceni0.2pd0.8in | 1 |
| 109 | centromere- | 1 |
| 110 | ceo/ml | 3 |
| 111 | children-iv | 2 |
| 112 | chiropodists/podiatrists | 1 |
| 113 | chloroquine-artesunate | 1 |
| 114 | cholecystocholedocholithiasis | 3 |
| 115 | cholesterol-reducer | 1 |
| 116 | chx+xpb | 2 |
| 117 | cilobradine | 3 |
| 118 | cis-prenyltransferases | 1 |
| 119 | clic1 | 2 |
| 120 | cnbss-1 | 2 |
| 121 | cnbss-2 | 2 |
| 122 | cns-symptoms | 1 |
| 123 | co-factors | 25 |
| 124 | co-pays | 3 |
| 125 | co-variables | 18 |
| 126 | co-variates | 20 |
| 127 | cofounders | 4 |
| 128 | cohabitants | 5 |
| 129 | colipase | 2 |
| 130 | colon-ovarian-tumor-antigen | 1 |
| 131 | confounders | 1,578 |
| 132 | confounders.thus | 1 |
| 133 | confounds | 61 |
| 134 | contactability | 2 |
| 135 | coulometry | 3 |
| 136 | counterfeiters | 1 |
| 137 | covariables | 68 |
| 138 | covariates | 2,553 |
| 139 | crinanes | 1 |
| 140 | crls1 | 1 |
| 141 | cross-tables | 2 |
| 142 | cta-pe | 1 |
| 143 | ctg-monitoring | 2 |
| 144 | cu2zn0.4fe0.6snse4 | 1 |
| 145 | cytokeratin-7 | 1 |
| 146 | d.farinae | 1 |
| 147 | d12sac010202 | 3 |
| 148 | d175n | 3 |
| 149 | data-triangulation | 1 |
| 150 | daytime-abpm | 1 |
| 151 | death.am | 1 |
| 152 | deconfounding | 1 |
| 153 | deltal | 2 |
| 154 | demographics | 2,089 |
| 155 | demography | 77 |
| 156 | depression-anxiety-panic | 1 |
| 157 | descriptives | 5 |
| 158 | dffb | 1 |
| 159 | dha-status | 2 |
| 160 | diabetes/prediabetes | 1 |
| 161 | dic-syndrome | 1 |
| 162 | disbenefits | 2 |
| 163 | discontinuation/safety | 1 |
| 164 | disease-self-management | 1 |
| 165 | disease-subtypes | 1 |
| 166 | dispensarisation | 1 |
| 167 | distant-ffr | 3 |
| 168 | doctor-patient-relationships | 1 |
| 169 | donuts | 8 |
| 170 | dwi-spair | 4 |
| 171 | dyslipidemiae | 1 |
| 172 | e180g | 4 |
| 173 | east-asians | 1 |
| 174 | ecphr | 1 |
| 175 | eeg-regulators | 2 |
| 176 | egg-donors | 1 |
| 177 | electropolished-benchmark-samples | 1 |
| 178 | eons | 1 |
| 179 | ethylcellulose/soluplus® | 1 |
| 180 | examinion | 1 |
| 181 | f-18-fdg-pet/ct | 1 |
| 182 | fathers/children | 1 |
| 183 | fbdc | 2 |
| 184 | fcv-9 | 2 |
| 185 | ferd | 3 |
| 186 | ffff | 2 |
| 187 | fimtm | 2 |
| 188 | fine-typing | 1 |
| 189 | fiproles | 2 |
| 190 | firestem2d | 2 |
| 191 | flare/non-response | 1 |
| 192 | foetotoxic | 1 |
| 193 | fom-tromethamine | 1 |
| 194 | fritaa | 1 |
| 195 | galacturonamide | 1 |
| 196 | gamebirds | 1 |
| 197 | gamma-pyrone | 1 |
| 198 | gd-do3a-butrol | 2 |
| 199 | gd-dtpa-bmea | 2 |
| 200 | genotoxicants | 4 |
| 201 | genotoxicity/clastogenicity | 1 |
| 202 | ghs/qol | 2 |
| 203 | gliz | 3 |
| 204 | glucostrophalloside | 1 |
| 205 | gvpi | 1 |
| 206 | ha-1/ha-3 | 1 |
| 207 | ha-utis | 2 |
| 208 | handpicking | 2 |
| 209 | hast-aqp4 | 2 |
| 210 | hemidystonia | 3 |
| 211 | hexafunctionalized | 1 |
| 212 | him- | 2 |
| 213 | his200 | 2 |
| 214 | hivdd | 5 |
| 215 | hna-5b | 1 |
| 216 | hplc-uv-detection | 1 |
| 217 | hpv-6-11-18 | 1 |
| 218 | hpv-74 | 1 |
| 219 | hpv-typing | 1 |
| 220 | hpv59 | 2 |
| 221 | hsa-telmisartan | 1 |
| 222 | hsbf | 1 |
| 223 | hydrozincite | 2 |
| 224 | hypermenorrhae | 1 |
| 225 | hypo-fertility | 1 |
| 226 | hypochodriasis | 1 |
| 227 | hypoliths | 4 |
| 228 | i-sfn | 7 |
| 229 | ibs-patients | 1 |
| 230 | ifn-action | 1 |
| 231 | iga-nephropathy | 1 |
| 232 | igf-1/il-6 | 1 |
| 233 | il1beta-511 | 3 |
| 234 | immunoquantitation | 1 |
| 235 | immunoreactants | 4 |
| 236 | imp3/glut-1 | 1 |
| 237 | in-mates | 1 |
| 238 | incentive* | 3 |
| 239 | inclusion.we | 2 |
| 240 | indapamide-trials | 1 |
| 241 | infant/newborn | 1 |
| 242 | inflamtion | 1 |
| 243 | interferents | 4 |
| 244 | interva-3 | 1 |
| 245 | invasives | 3 |
| 246 | iso-lines | 2 |
| 247 | isorynchophylline | 1 |
| 248 | isovolumic-sr | 1 |
| 249 | isrctn02309506 | 2 |
| 250 | isrctn06477126 | 2 |
| 251 | isrctn43453770 | 2 |
| 252 | jdentalcare | 1 |
| 253 | jo2-hepatitis | 1 |
| 254 | kidney-essence | 2 |
| 255 | kids™ | 2 |
| 256 | kind-relevant | 1 |
| 257 | kinesins | 4 |
| 258 | kitakomachi | 4 |
| 259 | l1-l4a | 1 |
| 260 | laryngectomess | 1 |
| 261 | laryngopathy | 1 |
| 262 | laryngopharyngitis | 4 |
| 263 | leguminosae-caesalpinoideae | 1 |
| 264 | leu213 | 1 |
| 265 | lev/cbz-cr | 2 |
| 266 | lipin-1 | 13 |
| 267 | lnauc0-∞ | 1 |
| 268 | luteolin-7-o-gentiobioside | 2 |
| 269 | lvdys-6 | 2 |
| 270 | m-iv | 2 |
| 271 | maskers | 8 |
| 272 | masking-or | 1 |
| 273 | mcpr3-7 | 2 |
| 274 | mechanotransducers | 3 |
| 275 | mediators-self-efficacy | 1 |
| 276 | mednar | 1 |
| 277 | melanomagenesis | 1 |
| 278 | melastatin | 30 |
| 279 | melastatin-3 | 1 |
| 280 | melastatin-like | 1 |
| 281 | micro-nutrients | 6 |
| 282 | microcomputers | 2 |
| 283 | mir-124-1 | 1 |
| 284 | miscibilities | 1 |
| 285 | misclassifications | 10 |
| 286 | mlh-1 | 2 |
| 287 | mmf/pred | 2 |
| 288 | mouthbreathing | 1 |
| 289 | mrtps | 1 |
| 290 | msm.2 | 1 |
| 291 | mucolipin | 2 |
| 292 | multifocality/recurrence | 1 |
| 293 | multiplus | 2 |
| 294 | n.h.s | 1 |
| 295 | n=15-20 | 1 |
| 296 | nabhs | 1 |
| 297 | nagss | 1 |
| 298 | nano-dnt | 1 |
| 299 | natriuresis/diuresis | 4 |
| 300 | nct00000608 | 2 |
| 301 | nct00183001 | 2 |
| 302 | nct00197730 | 2 |
| 303 | nct00279682 | 1 |
| 304 | nct00801502 | 5 |
| 305 | necaxantle | 2 |
| 306 | neoliberalization | 1 |
| 307 | neonicotinoids | 5 |
| 308 | nephropathogenicity | 1 |
| 309 | neuro-therapeutics | 1 |
| 310 | neuroprotectors | 1 |
| 311 | nf+fs | 1 |
| 312 | no-fill | 1 |
| 313 | non-abuse | 1 |
| 314 | non-attendence | 1 |
| 315 | non-dermatologist | 1 |
| 316 | non-enrolment | 3 |
| 317 | non-high-velocity | 1 |
| 318 | non-ophthalmologists | 1 |
| 319 | non-randomisation | 8 |
| 320 | non-randomization | 6 |
| 321 | non-recruitment | 2 |
| 322 | non-stemis | 1 |
| 323 | nonapproach | 2 |
| 324 | nonasthmatics | 4 |
| 325 | nonepileptics | 1 |
| 326 | n≤4 | 1 |
| 327 | obesogen | 1 |
| 328 | obscurus | 3 |
| 329 | odi/ahi | 1 |
| 330 | oftocotrienol | 1 |
| 331 | oral-antidiabetics | 3 |
| 332 | organization/analysis | 1 |
| 333 | osteoinductivity | 2 |
| 334 | outcomes.overall | 3 |
| 335 | over-50s | 2 |
| 336 | over-reassurance | 1 |
| 337 | oxide-electronics | 1 |
| 338 | p-gc | 2 |
| 339 | p.a150p | 3 |
| 340 | p.arg149cys | 1 |
| 341 | p24ag | 1 |
| 342 | pain/distress | 1 |
| 343 | palaeoflora | 1 |
| 344 | panicogen | 1 |
| 345 | parents/children | 1 |
| 346 | paromomycin-gentamicin | 2 |
| 347 | patients-without | 1 |
| 348 | pelotherapy | 1 |
| 349 | pentavalents | 1 |
| 350 | perception-altering | 1 |
| 351 | peroxins | 1 |
| 352 | pethidine/promethazine | 1 |
| 353 | pfhrp2-detection | 3 |
| 354 | phhs | 6 |
| 355 | phosphanes | 4 |
| 356 | photosensitivity/photorefractoriness | 1 |
| 357 | physiologic/structural | 2 |
| 358 | phytotoxins | 2 |
| 359 | plasticisers | 5 |
| 360 | pore-filling | 2 |
| 361 | post-diesel | 1 |
| 362 | post-test-results | 1 |
| 363 | posterity | 1 |
| 364 | poststain | 1 |
| 365 | ppd/ppp | 3 |
| 366 | pq1 | 4 |
| 367 | practice.2 | 1 |
| 368 | pre-exercise/rest | 2 |
| 369 | precipitants | 15 |
| 370 | pregnancy/family | 2 |
| 371 | preschool-children | 1 |
| 372 | preswim | 1 |
| 373 | psychoses-montreal | 1 |
| 374 | psychosis/agitation | 1 |
| 375 | pufa- | 5 |
| 376 | pyri | 4 |
| 377 | q24h/q12h | 1 |
| 378 | qd1-7 | 1 |
| 379 | qlfts | 9 |
| 380 | r-fluoxetine | 3 |
| 381 | r-population | 1 |
| 382 | radiopeptides | 4 |
| 383 | rbt-gat | 1 |
| 384 | re-experiencing | 13 |
| 385 | rebound/relapse | 3 |
| 386 | reciprocator | 1 |
| 387 | recorrenced | 1 |
| 388 | reencoding | 1 |
| 389 | rep+10'dex | 1 |
| 390 | responder-rates | 1 |
| 391 | ribosides | 1 |
| 392 | risk-cost | 2 |
| 393 | rmi1 | 1 |
| 394 | romosinuano-brahman | 3 |
| 395 | rosuvastatine | 3 |
| 396 | roughing | 2 |
| 397 | rp×rp | 1 |
| 398 | rs12379183 | 1 |
| 399 | rs3744028 | 3 |
| 400 | rs4245791 | 2 |
| 401 | rs5277 | 2 |
| 402 | rvr-achievers | 1 |
| 403 | saa/vsaa | 1 |
| 404 | scc150 | 1 |
| 405 | selection- | 2 |
| 406 | self-battery | 3 |
| 407 | self-centering | 2 |
| 408 | self-induction | 1 |
| 409 | sensitinogen | 2 |
| 410 | sensitizers/irritants | 1 |
| 411 | sex-specificity | 1 |
| 412 | shanghai-china | 1 |
| 413 | sharklet™ | 2 |
| 414 | shininess/oiliness | 1 |
| 415 | shortlisting | 1 |
| 416 | signalment | 18 |
| 417 | slc22a2/oct2 | 1 |
| 418 | snappi | 5 |
| 419 | snitrosohemoglobin | 1 |
| 420 | socio-demographics | 45 |
| 421 | sociodemographics | 95 |
| 422 | spirolides | 2 |
| 423 | stomy | 1 |
| 424 | study.similarly | 1 |
| 425 | sulfapral | 1 |
| 426 | sum-149 | 3 |
| 427 | superioris | 5 |
| 428 | surface-hardening | 1 |
| 429 | tac-b.i.d | 6 |
| 430 | tac-q.d | 6 |
| 431 | tavorite-mg0.5feso4f | 2 |
| 432 | tcse2 | 2 |
| 433 | tenatoprazole | 2 |
| 434 | teratogenity | 2 |
| 435 | terre-de-bas | 2 |
| 436 | thalamotomies | 1 |
| 437 | themotherapy | 1 |
| 438 | therapeuty | 1 |
| 439 | thermo-sensitizer | 1 |
| 440 | thermopriming | 2 |
| 441 | thiol-reactivity | 1 |
| 442 | thrombolysis-caused | 1 |
| 443 | tlhogwana | 1 |
| 444 | tooth-conserving | 1 |
| 445 | totpar-6 | 1 |
| 446 | toxiphores | 1 |
| 447 | trans-2,3-dideuterooxirane | 1 |
| 448 | transcystic-cholangiography | 1 |
| 449 | trichoscan® | 3 |
| 450 | turbinata | 4 |
| 451 | tvr-lead-in-nr | 1 |
| 452 | t→∞ | 4 |
| 453 | uchl-1 | 1 |
| 454 | um06 | 1 |
| 455 | umin000001841 | 2 |
| 456 | under-preparation | 1 |
| 457 | underascertainment | 1 |
| 458 | unhsps | 1 |
| 459 | unicoronal | 1 |
| 460 | ureum | 2 |
| 461 | uro-oncologists | 1 |
| 462 | vallanoid | 1 |
| 463 | vanilloid | 138 |
| 464 | vanilloid-1 | 8 |
| 465 | vanilloid1 | 1 |
| 466 | vannilloid | 2 |
| 467 | variables-expectation | 1 |
| 468 | video-tapes | 1 |
| 469 | vitligo | 1 |
| 470 | vsss | 1 |
| 471 | vulva/vagina | 2 |
| 472 | wadal | 3 |
| 473 | wcvs | 1 |
| 474 | web-sites | 2 |
| 475 | wholeness | 5 |
| 476 | wirths | 2 |
| 477 | wu-comparisons | 1 |
| 478 | xyl1 | 2 |
| 479 | y143r | 1 |
| 480 | zmat3 | 2 |
| 481 | α-adrenoceptors | 2 |
| 482 | αba | 2 |
| 483 | β-1,3-galactan | 5 |
| 484 | β-cedrene- | 1 |
| 485 | β-fructofuranosidases | 1 |
| 486 | μg.min/ml | 3 |
| 487 | ψm | 1 |
| 488 | ∆mip | 1 |
| 1 | incentive* | 3 |
| 2 | al* | 1 |
| 3 | augment* | 1 |
| 4 | pufa- | 5 |
| 5 | β-cedrene- | 1 |
| 6 | centromere- | 1 |
| 7 | him- | 2 |
| 8 | selection- | 2 |
| 9 | his200 | 2 |
| 10 | n=15-20 | 1 |
| 11 | nct00197730 | 2 |
| 12 | scc150 | 1 |
| 13 | acr20/70 | 1 |
| 14 | isrctn43453770 | 2 |
| 15 | mir-124-1 | 1 |
| 16 | vanilloid-1 | 8 |
| 17 | mlh-1 | 2 |
| 18 | uchl-1 | 1 |
| 19 | lipin-1 | 13 |
| 20 | cnbss-1 | 2 |
| 21 | imp3/glut-1 | 1 |
| 22 | nct00183001 | 2 |
| 23 | il1beta-511 | 3 |
| 24 | umin000001841 | 2 |
| 25 | rs4245791 | 2 |
| 26 | aldh9a1 | 1 |
| 27 | 1-oh-mc/hsult1b1 | 1 |
| 28 | clic1 | 2 |
| 29 | vanilloid1 | 1 |
| 30 | rmi1 | 1 |
| 31 | asrgl1 | 1 |
| 32 | xyl1 | 2 |
| 33 | pq1 | 4 |
| 34 | crls1 | 1 |
| 35 | cnbss-2 | 2 |
| 36 | cam5.2 | 2 |
| 37 | practice.2 | 1 |
| 38 | msm.2 | 1 |
| 39 | causes.2 | 1 |
| 40 | d12sac010202 | 3 |
| 41 | nct00801502 | 5 |
| 42 | 2005-12 | 1 |
| 43 | 1973-2012 | 1 |
| 44 | nct00279682 | 1 |
| 45 | tcse2 | 2 |
| 46 | afg3l2 | 1 |
| 47 | slc22a2/oct2 | 1 |
| 48 | ha-1/ha-3 | 1 |
| 49 | interva-3 | 1 |
| 50 | canonical-3 | 1 |
| 51 | melastatin-3 | 1 |
| 52 | 0.9≤abi≤1.3 | 1 |
| 53 | 11q22.3-q23.3 | 2 |
| 54 | ald.3 | 1 |
| 55 | leu213 | 1 |
| 56 | rs12379183 | 1 |
| 57 | zmat3 | 2 |
| 58 | blactx-m14 | 1 |
| 59 | hpv-74 | 1 |
| 60 | cu2zn0.4fe0.6snse4 | 1 |
| 61 | hast-aqp4 | 2 |
| 62 | n≤4 | 1 |
| 63 | bip-135 | 2 |
| 64 | 1994/95 | 2 |
| 65 | b3-b5 | 1 |
| 66 | igf-1/il-6 | 1 |
| 67 | totpar-6 | 1 |
| 68 | lvdys-6 | 2 |
| 69 | isrctn02309506 | 2 |
| 70 | um06 | 1 |
| 71 | isrctn06477126 | 2 |
| 72 | auc0-36 | 6 |
| 73 | qd1-7 | 1 |
| 74 | mcpr3-7 | 2 |
| 75 | cytokeratin-7 | 1 |
| 76 | rs5277 | 2 |
| 77 | 1980-1987 | 2 |
| 78 | nct00000608 | 2 |
| 79 | hpv-6-11-18 | 1 |
| 80 | rs3744028 | 3 |
| 81 | 14,278 | 1 |
| 82 | fcv-9 | 2 |
| 83 | sum-149 | 3 |
| 84 | hpv59 | 2 |
| 85 | l1-l4a | 1 |
| 86 | saa/vsaa | 1 |
| 87 | fritaa | 1 |
| 88 | αba | 2 |
| 89 | gd-dtpa-bmea | 2 |
| 90 | -nausea | 1 |
| 91 | hemidystonia | 3 |
| 92 | tlhogwana | 1 |
| 93 | vulva/vagina | 2 |
| 94 | shanghai-china | 1 |
| 95 | palaeoflora | 1 |
| 96 | turbinata | 4 |
| 97 | 43b | 1 |
| 98 | hna-5b | 1 |
| 99 | dffb | 1 |
| 100 | chx+xpb | 2 |
| 101 | c1qb | 1 |
| 102 | 181c | 1 |
| 103 | ag85c | 2 |
| 104 | fbdc | 2 |
| 105 | p-gc | 2 |
| 106 | antihypercholesterolaemic | 2 |
| 107 | depression-anxiety-panic | 1 |
| 108 | foetotoxic | 1 |
| 109 | tac-b.i.d | 6 |
| 110 | tac-q.d | 6 |
| 111 | 80-120mg/d | 5 |
| 112 | 8mg/d | 8 |
| 113 | 12h/d | 1 |
| 114 | firestem2d | 2 |
| 115 | 174d | 1 |
| 116 | hivdd | 5 |
| 117 | recorrenced | 1 |
| 118 | mmf/pred | 2 |
| 119 | thrombolysis-caused | 1 |
| 120 | body-temperature-and-pressure-saturated | 1 |
| 121 | hexafunctionalized | 1 |
| 122 | vanilloid | 138 |
| 123 | vannilloid | 2 |
| 124 | vallanoid | 1 |
| 125 | ferd | 3 |
| 126 | leguminosae-caesalpinoideae | 1 |
| 127 | hypermenorrhae | 1 |
| 128 | dyslipidemiae | 1 |
| 129 | d.farinae | 1 |
| 130 | over-reassurance | 1 |
| 131 | non-attendence | 1 |
| 132 | multifocality/recurrence | 1 |
| 133 | kidney-essence | 2 |
| 134 | azodicarbonamide | 3 |
| 135 | galacturonamide | 1 |
| 136 | luteolin-7-o-gentiobioside | 2 |
| 137 | anti-chitobioside | 4 |
| 138 | glucostrophalloside | 1 |
| 139 | analgesie | 1 |
| 140 | melastatin-like | 1 |
| 141 | tenatoprazole | 2 |
| 142 | necaxantle | 2 |
| 143 | dic-syndrome | 1 |
| 144 | 2-methyl-1,3-dioxolane | 2 |
| 145 | trans-2,3-dideuterooxirane | 1 |
| 146 | cilobradine | 3 |
| 147 | 123-iodine | 1 |
| 148 | isorynchophylline | 1 |
| 149 | fom-tromethamine | 1 |
| 150 | benzoylecgnonine | 1 |
| 151 | rosuvastatine | 3 |
| 152 | r-fluoxetine | 3 |
| 153 | pethidine/promethazine | 1 |
| 154 | 7,7'-biphenyl-2,2'-bitropone | 2 |
| 155 | gamma-pyrone | 1 |
| 156 | cta-pe | 1 |
| 157 | jdentalcare | 1 |
| 158 | colipase | 2 |
| 159 | flare/non-response | 1 |
| 160 | 13c6-d-glucose | 1 |
| 161 | rebound/relapse | 3 |
| 162 | non-abuse | 1 |
| 163 | chloroquine-artesunate | 1 |
| 164 | hydrozincite | 2 |
| 165 | inclusion.we | 2 |
| 166 | tavorite-mg0.5feso4f | 2 |
| 167 | hsbf | 1 |
| 168 | ffff | 2 |
| 169 | alpha-lf | 4 |
| 170 | algimycin-pwf | 2 |
| 171 | acei+g | 3 |
| 172 | e180g | 4 |
| 173 | p24ag | 1 |
| 174 | re-experiencing | 13 |
| 175 | deconfounding | 1 |
| 176 | reencoding | 1 |
| 177 | roughing | 2 |
| 178 | mouthbreathing | 1 |
| 179 | handpicking | 2 |
| 180 | pore-filling | 2 |
| 181 | thermopriming | 2 |
| 182 | surface-hardening | 1 |
| 183 | fine-typing | 1 |
| 184 | hpv-typing | 1 |
| 185 | perception-altering | 1 |
| 186 | self-centering | 2 |
| 187 | ctg-monitoring | 2 |
| 188 | shortlisting | 1 |
| 189 | androgen-boosting | 1 |
| 190 | assistant-sitting | 1 |
| 191 | tooth-conserving | 1 |
| 192 | balloon-oversizing | 1 |
| 193 | q24h/q12h | 1 |
| 194 | 5.3h | 1 |
| 195 | 75h | 1 |
| 196 | 79h | 1 |
| 197 | nonapproach | 2 |
| 198 | odi/ahi | 1 |
| 199 | kitakomachi | 4 |
| 200 | snappi | 5 |
| 201 | gvpi | 1 |
| 202 | pyri | 4 |
| 203 | afasi | 1 |
| 204 | wadal | 3 |
| 205 | psychoses-montreal | 1 |
| 206 | unicoronal | 1 |
| 207 | sulfapral | 1 |
| 208 | physiologic/structural | 2 |
| 209 | deltal | 2 |
| 210 | post-diesel | 1 |
| 211 | outcomes.overall | 3 |
| 212 | no-fill | 1 |
| 213 | μg.min/ml | 3 |
| 214 | ceo/ml | 3 |
| 215 | oftocotrienol | 1 |
| 216 | ghs/qol | 2 |
| 217 | 'adaptation-control | 1 |
| 218 | gd-do3a-butrol | 2 |
| 219 | 3.2m | 1 |
| 220 | death.am | 1 |
| 221 | cefotaxim/sulbactam | 1 |
| 222 | preswim | 1 |
| 223 | daytime-abpm | 1 |
| 224 | fimtm | 2 |
| 225 | ureum | 2 |
| 226 | acutum | 8 |
| 227 | ψm | 1 |
| 228 | d175n | 3 |
| 229 | romosinuano-brahman | 3 |
| 230 | β-1,3-galactan | 5 |
| 231 | hsa-telmisartan | 1 |
| 232 | colon-ovarian-tumor-antigen | 1 |
| 233 | panicogen | 1 |
| 234 | sensitinogen | 2 |
| 235 | obesogen | 1 |
| 236 | preschool-children | 1 |
| 237 | fathers/children | 1 |
| 238 | parents/children | 1 |
| 239 | i-sfn | 7 |
| 240 | bedding-in | 2 |
| 241 | ceni0.2pd0.8in | 1 |
| 242 | poststain | 1 |
| 243 | snitrosohemoglobin | 1 |
| 244 | paromomycin-gentamicin | 2 |
| 245 | 15-60min | 1 |
| 246 | adcmin | 3 |
| 247 | mucolipin | 2 |
| 248 | melastatin | 30 |
| 249 | aspirin/pravastatin | 1 |
| 250 | carbapenem-colistin | 1 |
| 251 | 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin | 1 |
| 252 | examinion | 1 |
| 253 | cell-cell-adhesion | 1 |
| 254 | data-triangulation | 1 |
| 255 | r-population | 1 |
| 256 | under-preparation | 1 |
| 257 | non-randomisation | 8 |
| 258 | dispensarisation | 1 |
| 259 | variables-expectation | 1 |
| 260 | psychosis/agitation | 1 |
| 261 | immunoquantitation | 1 |
| 262 | neoliberalization | 1 |
| 263 | non-randomization | 6 |
| 264 | ifn-action | 1 |
| 265 | pfhrp2-detection | 3 |
| 266 | hplc-uv-detection | 1 |
| 267 | self-induction | 1 |
| 268 | inflamtion | 1 |
| 269 | angioprevention | 3 |
| 270 | atheroprevention | 2 |
| 271 | infant/newborn | 1 |
| 272 | vitligo | 1 |
| 273 | 2decho | 1 |
| 274 | p.a150p | 3 |
| 275 | bi-pap | 2 |
| 276 | ∆mip | 1 |
| 277 | ppd/ppp | 3 |
| 278 | rp×rp | 1 |
| 279 | y143r | 1 |
| 280 | mednar | 1 |
| 281 | lev/cbz-cr | 2 |
| 282 | cholesterol-reducer | 1 |
| 283 | thermo-sensitizer | 1 |
| 284 | distant-ffr | 3 |
| 285 | ecphr | 1 |
| 286 | dwi-spair | 4 |
| 287 | tvr-lead-in-nr | 1 |
| 288 | masking-or | 1 |
| 289 | alachlor | 3 |
| 290 | reciprocator | 1 |
| 291 | isovolumic-sr | 1 |
| 292 | n.h.s | 1 |
| 293 | over-50s | 2 |
| 294 | terre-de-bas | 2 |
| 295 | cellulitis/erysipelas | 4 |
| 296 | anthicolinergics | 1 |
| 297 | demographics | 2,089 |
| 298 | socio-demographics | 45 |
| 299 | sociodemographics | 95 |
| 300 | aphakics | 1 |
| 301 | oxide-electronics | 1 |
| 302 | nonasthmatics | 4 |
| 303 | oral-antidiabetics | 3 |
| 304 | nonepileptics | 1 |
| 305 | neuro-therapeutics | 1 |
| 306 | neonicotinoids | 5 |
| 307 | confounds | 61 |
| 308 | boulevards | 2 |
| 309 | gamebirds | 1 |
| 310 | 2-chloro-des | 2 |
| 311 | spirolides | 2 |
| 312 | ribosides | 1 |
| 313 | radiopeptides | 4 |
| 314 | 1h-1,2,3-triazolylbenzohydrazides | 2 |
| 315 | aneuploidies | 71 |
| 316 | thalamotomies | 1 |
| 317 | miscibilities | 1 |
| 318 | co-variables | 18 |
| 319 | covariables | 68 |
| 320 | cross-tables | 2 |
| 321 | fiproles | 2 |
| 322 | electropolished-benchmark-samples | 1 |
| 323 | phosphanes | 4 |
| 324 | crinanes | 1 |
| 325 | iso-lines | 2 |
| 326 | borderlines | 11 |
| 327 | 19-norprogesterones | 2 |
| 328 | video-tapes | 1 |
| 329 | appes | 1 |
| 330 | disease-subtypes | 1 |
| 331 | toxiphores | 1 |
| 332 | caricatures | 4 |
| 333 | β-fructofuranosidases | 1 |
| 334 | cis-prenyltransferases | 1 |
| 335 | adresses | 1 |
| 336 | co-variates | 20 |
| 337 | covariates | 2,553 |
| 338 | in-mates | 1 |
| 339 | responder-rates | 1 |
| 340 | diabetes/prediabetes | 1 |
| 341 | web-sites | 2 |
| 342 | invasives | 3 |
| 343 | ablatives | 1 |
| 344 | descriptives | 5 |
| 345 | calibration-curves | 1 |
| 346 | awes | 9 |
| 347 | nf+fs | 1 |
| 348 | atfs | 3 |
| 349 | nabhs | 1 |
| 350 | phhs | 6 |
| 351 | hypoliths | 4 |
| 352 | 3.5months | 1 |
| 353 | 48months | 1 |
| 354 | wirths | 2 |
| 355 | non-stemis | 1 |
| 356 | superioris | 5 |
| 357 | cholecystocholedocholithiasis | 3 |
| 358 | hypochodriasis | 1 |
| 359 | melanomagenesis | 1 |
| 360 | natriuresis/diuresis | 4 |
| 361 | catharsis | 11 |
| 362 | organization/analysis | 1 |
| 363 | laryngopharyngitis | 4 |
| 364 | jo2-hepatitis | 1 |
| 365 | ha-utis | 2 |
| 366 | 12-24weeks | 2 |
| 367 | indapamide-trials | 1 |
| 368 | b-nhls | 3 |
| 369 | cns-symptoms | 1 |
| 370 | biomechanisms | 3 |
| 371 | east-asians | 1 |
| 372 | kinesins | 4 |
| 373 | peroxins | 1 |
| 374 | phytotoxins | 2 |
| 375 | eons | 1 |
| 376 | misclassifications | 10 |
| 377 | bio-applications | 2 |
| 378 | wu-comparisons | 1 |
| 379 | doctor-patient-relationships | 1 |
| 380 | unhsps | 1 |
| 381 | mrtps | 1 |
| 382 | 365.3person-years | 1 |
| 383 | biochars/hydrochars | 1 |
| 384 | anti-tuberculars | 1 |
| 385 | mechanotransducers | 3 |
| 386 | confounders | 1,578 |
| 387 | cofounders | 4 |
| 388 | bridgers | 4 |
| 389 | maskers | 8 |
| 390 | astronomers | 2 |
| 391 | plasticisers | 5 |
| 392 | counterfeiters | 1 |
| 393 | microcomputers | 2 |
| 394 | rvr-achievers | 1 |
| 395 | egg-donors | 1 |
| 396 | eeg-regulators | 2 |
| 397 | co-factors | 25 |
| 398 | neuroprotectors | 1 |
| 399 | beta-2-receptors | 1 |
| 400 | α-adrenoceptors | 2 |
| 401 | laryngectomess | 1 |
| 402 | wholeness | 5 |
| 403 | shininess/oiliness | 1 |
| 404 | photosensitivity/photorefractoriness | 1 |
| 405 | pain/distress | 1 |
| 406 | nagss | 1 |
| 407 | vsss | 1 |
| 408 | qlfts | 9 |
| 409 | disbenefits | 2 |
| 410 | beta-subunits | 5 |
| 411 | post-test-results | 1 |
| 412 | genotoxicants | 4 |
| 413 | bioinoculants | 1 |
| 414 | immunoreactants | 4 |
| 415 | cohabitants | 5 |
| 416 | precipitants | 15 |
| 417 | sensitizers/irritants | 1 |
| 418 | micro-nutrients | 6 |
| 419 | ibs-patients | 1 |
| 420 | pentavalents | 1 |
| 421 | interferents | 4 |
| 422 | uro-oncologists | 1 |
| 423 | allergologists | 2 |
| 424 | non-ophthalmologists | 1 |
| 425 | chiropodists/podiatrists | 1 |
| 426 | donuts | 8 |
| 427 | confounders.thus | 1 |
| 428 | multiplus | 2 |
| 429 | obscurus | 3 |
| 430 | dha-status | 2 |
| 431 | wcvs | 1 |
| 432 | 1h/day/21days | 1 |
| 433 | 31days | 1 |
| 434 | auc0-7days | 2 |
| 435 | 21/28days | 1 |
| 436 | co-pays | 3 |
| 437 | p.arg149cys | 1 |
| 438 | rbt-gat | 1 |
| 439 | f-18-fdg-pet/ct | 1 |
| 440 | kind-relevant | 1 |
| 441 | nano-dnt | 1 |
| 442 | disease-self-management | 1 |
| 443 | signalment | 18 |
| 444 | non-enrolment | 3 |
| 445 | underascertainment | 1 |
| 446 | antitreatment | 1 |
| 447 | non-recruitment | 2 |
| 448 | pre-exercise/rest | 2 |
| 449 | non-dermatologist | 1 |
| 450 | risk-cost | 2 |
| 451 | patients-without | 1 |
| 452 | m-iv | 2 |
| 453 | children-iv | 2 |
| 454 | rep+10'dex | 1 |
| 455 | mediators-self-efficacy | 1 |
| 456 | astrology | 5 |
| 457 | transcystic-cholangiography | 1 |
| 458 | demography | 77 |
| 459 | laryngopathy | 1 |
| 460 | iga-nephropathy | 1 |
| 461 | pregnancy/family | 2 |
| 462 | study.similarly | 1 |
| 463 | stomy | 1 |
| 464 | pelotherapy | 1 |
| 465 | themotherapy | 1 |
| 466 | self-battery | 3 |
| 467 | coulometry | 3 |
| 468 | discontinuation/safety | 1 |
| 469 | sex-specificity | 1 |
| 470 | nephropathogenicity | 1 |
| 471 | genotoxicity/clastogenicity | 1 |
| 472 | non-high-velocity | 1 |
| 473 | contactability | 2 |
| 474 | hypo-fertility | 1 |
| 475 | teratogenity | 2 |
| 476 | posterity | 1 |
| 477 | ambidexterity | 4 |
| 478 | thiol-reactivity | 1 |
| 479 | osteoinductivity | 2 |
| 480 | therapeuty | 1 |
| 481 | b-pa-z | 2 |
| 482 | gliz | 3 |
| 483 | lnauc0-∞ | 1 |
| 484 | t→∞ | 4 |
| 485 | kids™ | 2 |
| 486 | sharklet™ | 2 |
| 487 | trichoscan® | 3 |
| 488 | ethylcellulose/soluplus® | 1 |